Articles with "mivebresib abbv" as a keyword



Photo by keenangrams from unsplash

Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML

Sign Up to like & get
recommendations!
Published in 2022 at "In Vivo"

DOI: 10.21873/invivo.12872

Abstract: Background/Aim: The therapeutic potential of bromodomain and extra-terminal motif (BET) inhibitors in hematological cancers has been well established in preclinical and early-stage clinical trials, although as of yet, no BETtargeting agent has achieved approval. To… read more here.

Keywords: bet; mivebresib abbv; abbv 075; clinical modeling ... See more keywords